{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:18:58Z","timestamp":1791425938843,"version":"4.3.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10096-017-2913-z","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T14:58:14Z","timestamp":1488812294000},"page":"1225-1230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-5240","authenticated-orcid":false,"given":"C.","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"2913_CR1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/bmj.322.7287.658","volume":"322","author":"J Ross","year":"2001","unstructured":"Ross J (2001) Pelvic inflammatory disease. BMJ 322:658\u2013659","journal-title":"BMJ"},{"key":"2913_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/AOG.0b013e3181e75a4a","volume":"116","author":"E David","year":"2010","unstructured":"David E (2010) Pelvic inflammatory disease. Obstet Gynecol 116:419\u2013428","journal-title":"Obstet Gynecol"},{"key":"2913_CR3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/OLQ.0b013e3181f22f3e","volume":"38","author":"CE French","year":"2011","unstructured":"French CE, Hughes G, Nicholson A, Yung M, RossJD WT et al (2011) Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000\u20132008. Sex Transm Dis 38:158\u2013162","journal-title":"Sex Transm Dis"},{"key":"2913_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0956462413498714","volume":"25","author":"J Ross","year":"2014","unstructured":"Ross J, Judlin P, Jensen J (2014) 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 25:1\u20137","journal-title":"Int J STD AIDS"},{"key":"2913_CR5","first-page":"1","volume":"59","author":"KA Workowski","year":"2010","unstructured":"Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC) (2010) Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 59:1\u2013110","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"2913_CR6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14656566.2015.1035255","volume":"16","author":"S Ryan","year":"2015","unstructured":"Ryan S, Jack DS (2015) Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother 16(7):1109\u20131115","journal-title":"Expert Opin Pharmacother"},{"key":"2913_CR7","unstructured":"AF L (2008) inventor; Jeekai Intellectual Property Limited, assignee. Usage of alpha-(morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines. China Patent ZL 200510134254. 3: 636-643"},{"key":"2913_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00007435-197710000-00001","volume":"4","author":"WM McCormack","year":"1977","unstructured":"McCormack WM, Nowroozi K, Alpert S et al (1977) Acute pelvic inflammatory disease: characteristics of patients with gonococcal and nongonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin G and spectinomycin hydrochloride. Sex Transm Dis 4:125\u2013131","journal-title":"Sex Transm Dis"},{"key":"2913_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2015.05.004","volume":"46","author":"R Duarte","year":"2015","unstructured":"Duarte R, Fuhrich D, Ross JD (2015) A review of antibiotic therapy for pelvic inflammatory disease. Int J Antimicrob Agents 46:272\u2013277","journal-title":"Int J Antimicrob Agents"},{"key":"2913_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2015.11.028","volume":"134","author":"JL Brun","year":"2016","unstructured":"Brun JL, Graesslin O, Fauconnier A et al (2016) Updated French guidelines for diagnosis and management of pelvic inflammatory disease. Int J Gynaecol Obstet 134:121\u2013125","journal-title":"Int J Gynaecol Obstet"},{"key":"2913_CR11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/AAC.14.3.384","volume":"14","author":"J Wust","year":"1978","unstructured":"Wust J (1978) Susceptibiliity of anaerobic bacteria to metronidazole, ornidazole and tinidazole and routine therapy by standardized methods. Antimicrob Agents Chemother 14:609\u2013613","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2913_CR12","first-page":"158","volume":"13","author":"S Yu","year":"2004","unstructured":"Yu S, Wen A, Xi X (2004) Clinical effect of ornidazole injection in treatment of anaerobic infections in gynecology. Chin J New Drug 13(2):158\u2013160","journal-title":"Chin J New Drug"},{"issue":"1","key":"2913_CR13","first-page":"9","volume":"90","author":"S Bassily","year":"1987","unstructured":"Bassily S, Farid Z et al (1987) Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole and ornidazole: a comparative study. J Trop Med Hyg 90(1):9\u201312","journal-title":"J Trop Med Hyg"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-2913-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T08:36:38Z","timestamp":1499070998000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-2913-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-2913-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]}}}